Derivative Financial Instruments (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Sep. 24, 2021
Derivative Financial Instruments (Details) [Line Items]
Expire date	Sep. 24, 2026
Non voting common stock	$ 911,022
Warrants	4,999,863
Fair value equity	0.7
Recognized gain (loss)	$ 600,000	$ 6,100,000
Fair value of common stock				$ 200,000
Description of contingent earnout liability	Upon the closing of the Business Combination and pursuant to the Sponsor Support Agreement, the Sponsor agreed to place the Earnout Shares into escrow, which will be released as follows: (a) 250,000 Earnout Shares will be released if, during the period from and after September 24, 2021 until September 24, 2024 (the “Earnout Period”), over any twenty trading days within any thirty day consecutive trading day period, the volume-weighted average price of the Company’s common stock (the “Applicable VWAP”) is greater than or equal to $11.50, (b) 500,000 Earnout Shares will be released if, during the Earnout Period, the Applicable VWAP is greater than or equal to $15.00, and (c) 300,000 Earnout Shares will be released if, during the Earnout Period, the Applicable VWAP is greater than or equal to $18.00 (the “triggering events”).
Common stock warrants fair value	$ 800,000		$ 100,000
Monte Carlo Simulation Model [Member]
Derivative Financial Instruments (Details) [Line Items]
Recognized gain (loss)	$ 0.8	$ 4,600,000